Renee Risingsong

2.9k total citations
30 papers, 2.5k citations indexed

About

Renee Risingsong is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Renee Risingsong has authored 30 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Genetics. Recurrent topics in Renee Risingsong's work include Genomics, phytochemicals, and oxidative stress (13 papers), Natural product bioactivities and synthesis (7 papers) and Estrogen and related hormone effects (7 papers). Renee Risingsong is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (13 papers), Natural product bioactivities and synthesis (7 papers) and Estrogen and related hormone effects (7 papers). Renee Risingsong collaborates with scholars based in United States, United Kingdom and Netherlands. Renee Risingsong's co-authors include Michael B. Sporn, Charlotte R. Williams, Karen T. Liby, Darlene B. Royce, Nanjoo Suh, Tadashi Honda, Gordon W. Gribble, Katherine K. Stephenson, Albena T. Dinkova‐Kostova and Mark M. Yore and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Renee Risingsong

30 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renee Risingsong United States	26	2.0k	356	354	239	219	30	2.5k
Charlotte R. Williams United States	32	2.8k 1.4×	480 1.3×	462 1.3×	329 1.4×	289 1.3×	41	3.6k
Sung‐Gook Cho South Korea	27	1.3k 0.6×	403 1.1×	315 0.9×	147 0.6×	165 0.8×	60	2.2k
Darlene B. Royce United States	25	1.3k 0.7×	288 0.8×	192 0.5×	167 0.7×	193 0.9×	39	1.7k
Wayne C. Glasgow United States	26	899 0.5×	155 0.4×	283 0.8×	254 1.1×	244 1.1×	46	1.9k
Venugopal Radjendirane United States	13	1.9k 0.9×	141 0.4×	192 0.5×	141 0.6×	122 0.6×	16	2.3k
Chun‐Yin Huang Taiwan	30	1.2k 0.6×	463 1.3×	411 1.2×	89 0.4×	321 1.5×	60	2.2k
Dong Joon Kim China	25	1.4k 0.7×	320 0.9×	404 1.1×	101 0.4×	191 0.9×	58	2.0k
ShouWei Han United States	20	1.1k 0.5×	266 0.7×	412 1.2×	116 0.5×	167 0.8×	30	1.6k
Larisa Nonn United States	30	1.5k 0.8×	411 1.2×	772 2.2×	316 1.3×	168 0.8×	69	2.9k
Ke Yao United States	28	1.5k 0.7×	389 1.1×	298 0.8×	89 0.4×	162 0.7×	61	2.0k

Countries citing papers authored by Renee Risingsong

Since Specialization

Citations

This map shows the geographic impact of Renee Risingsong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renee Risingsong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renee Risingsong more than expected).

Fields of papers citing papers by Renee Risingsong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renee Risingsong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renee Risingsong. The network helps show where Renee Risingsong may publish in the future.

Co-authorship network of co-authors of Renee Risingsong

This figure shows the co-authorship network connecting the top 25 collaborators of Renee Risingsong. A scholar is included among the top collaborators of Renee Risingsong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renee Risingsong. Renee Risingsong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Royce, Darlene B., et al.. (2015). The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice. Cancer Prevention Research. 9(1). 105–114. 19 indexed citations

To, Ciric, Carol S. Ringelberg, Darlene B. Royce, et al.. (2015). Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis. Carcinogenesis. 36(7). 769–781. 60 indexed citations

To, Ciric, Eun‐Hee Kim, Darlene B. Royce, et al.. (2014). The PARP Inhibitors, Veliparib and Olaparib, Are Effective Chemopreventive Agents for Delaying Mammary Tumor Development in BRCA1-deficient Mice. Cancer Prevention Research. 7(7). 698–707. 60 indexed citations

Tran, Kim‐Vy, Renee Risingsong, Darlene B. Royce, et al.. (2012). The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor–Negative Mammary Carcinogenesis in Polyoma Middle T Mice. Cancer Prevention Research. 5(5). 726–734. 40 indexed citations

Risingsong, Renee, Darlene B. Royce, Charlotte R. Williams, et al.. (2012). The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer. Carcinogenesis. 34(1). 199–210. 40 indexed citations

Calingasan, Noel Y., Elizabeth Wille, Susanne Petri, et al.. (2011). Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radical Biology and Medicine. 51(1). 88–96. 171 indexed citations

Liby, Karen T., Darlene B. Royce, Renee Risingsong, et al.. (2010). Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer. Cancer Prevention Research. 3(11). 1427–1434. 78 indexed citations

Liby, Karen T., Renee Risingsong, Darlene B. Royce, et al.. (2009). Triterpenoids CDDO-Methyl Ester or CDDO-Ethyl Amide and Rexinoids LG100268 or NRX194204 for Prevention and Treatment of Lung Cancer in Mice. Cancer Prevention Research. 2(12). 1050–1058. 50 indexed citations

Yang, Lichuan, Noel Y. Calingasan, Bobby Thomas, et al.. (2009). Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription. PLoS ONE. 4(6). e5757–e5757. 144 indexed citations

10.

Liby, Karen T., Renee Risingsong, Darlene B. Royce, et al.. (2008). Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268. Clinical Cancer Research. 14(14). 4556–4563. 66 indexed citations

11.

Liby, Karen T., Mark M. Yore, Bill D. Roebuck, et al.. (2008). A Novel Acetylenic Tricyclic bis-(Cyano Enone) Potently Induces Phase 2 Cytoprotective Pathways and Blocks Liver Carcinogenesis Induced by Aflatoxin. Cancer Research. 68(16). 6727–6733. 42 indexed citations

12.

Liby, Karen T., Darlene B. Royce, Renee Risingsong, et al.. (2006). The triterpenoid, CDDO-methyl ester, and the rexinoid, LG100268, synergize in the prevention of mammary tumors in a mouse model of estrogen receptor-negative breast cancer.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

13.

Honda, Tadashi, Karen T. Liby, Chitra Sundararajan, et al.. (2006). Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A. Bioorganic & Medicinal Chemistry Letters. 16(24). 6306–6309. 40 indexed citations

14.

Liby, Karen T., Nga Voong, Charlotte R. Williams, et al.. (2006). The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells. Clinical Cancer Research. 12(14). 4288–4293. 98 indexed citations

15.

Liby, Karen T., Thomas Hock, Mark M. Yore, et al.. (2005). The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling. Cancer Research. 65(11). 4789–4798. 239 indexed citations

16.

Dinkova‐Kostova, Albena T., Karen T. Liby, Katherine K. Stephenson, et al.. (2005). Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress. Proceedings of the National Academy of Sciences. 102(12). 4584–4589. 493 indexed citations

17.

Rendi, Mara H., Nanjoo Suh, William W. Lamph, et al.. (2004). The Selective Estrogen Receptor Modulator Arzoxifene and the Rexinoid LG100268 Cooperate to Promote Transforming Growth Factor β-Dependent Apoptosis in Breast Cancer. Cancer Research. 64(10). 3566–3571. 54 indexed citations

18.

Suh, Nanjoo, Anita B. Roberts, Stephanie Birkey Reffey, et al.. (2003). Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.. PubMed. 63(6). 1371–6. 76 indexed citations

19.

Place, Andrew E., Nanjoo Suh, Charlotte R. Williams, et al.. (2003). The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.. PubMed. 9(7). 2798–806. 124 indexed citations

20.

Suh, Nanjoo, William W. Lamph, Andrew L. Glasebrook, et al.. (2002). Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268.. PubMed. 8(10). 3270–5. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact